Corpus Intelligence IC Memo — OCHSNER REHABILITATION HOSPITAL 2026-04-26 15:54 UTC
IC Memo — OCHSNER REHABILITATION HOSPITAL
Investment Committee Memorandum | LA | 56 beds | Grade C | EBITDA uplift $1.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

OCHSNER REHABILITATION HOSPITAL

CCN 193099 | JEFFERSON, LA | 56 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

OCHSNER REHABILITATION HOSPITAL is a 56-bed community hospital in JEFFERSON, LA with $23.3M in net patient revenue and a -4.9% operating margin. The hospital serves a payer mix of 34.0% Medicare, 0.0% Medicaid, and 66.0% commercial.

Thesis: Turnaround. Our ML models identify $1.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -4.9% to 2.4% (+736bps).

Net Revenue HCRIS$23.3M
Current EBITDA COMPUTED$-1.2M
Operating Margin COMPUTED-4.9%
Occupancy HCRIS75.6%
Revenue / Bed COMPUTED$416K
Net-to-Gross HCRIS30.2%
Distress Probability MLnan%

2. Market Context & Competitive Position

212
LA Hospitals
-3.5%
State Median Margin
84
Comparable Hospitals

LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of -4.9% places it below the state median. Among 84 size-comparable peers (28-112 beds), the median margin is -3.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (28-112), prioritizing same-state peers. 84 hospitals in the comp set.

HospitalStateBedsRevenueMargin
OCHSNER REHABILITATION HOSPITA (Target)LA56$23.3M-4.9%
ST. PATRICK HOSPITALLA100$189.4M-7.4%
UNIVERSITY HOSPITAL & CLINICSLA52$158.9M-33.4%
SOUTHERN REGIONAL MEDICAL CORPLA64$97.3M-50.0%
OCHSNER LSU HEALTH MONROELA84$85.1M-50.0%
NATCHITOCHES REGIONAL MEDICAL LA81$82.4M-21.8%
LAKE AREA MEDICAL CENTERLA88$81.6M2.2%
NEW ORLEANS EAST HOSPITALLA60$77.6M-29.7%
LANE REGIONAL MEDICAL CENTERLA109$76.5M-43.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$489K+210bp18mo
Cost to Collect4.5%2.5%$466K+200bp12mo
Denial Rate Reduction12.0%6.5%$461K+198bp12mo
A/R Days Reduction5200.0%3800.0%$283K+122bp9mo
Clean Claim Rate88.0%96.0%$15K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$489K
Cost to Collect
$466K
Denial Rate Reduction
$461K
A/R Days Reduction
$283K
Clean Claim Rate
$15K
Total EBITDA Uplift$1.7M
Current EBITDA$-1.2M
+ RCM Uplift+$1.7M
Pro Forma EBITDA$563K
Current Margin-4.9%
Pro Forma Margin2.4%
WC Released (1x)$893K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.8M$9.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.8M$9.9M0.00x-100.0%
Bull Case9.0x11.0x$-1.6M$15.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.6M$15.9M0.00x-100.0%
Bear Case11.0x10.0x$-1.9M$1.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.9M$1.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 84 hospitals with 28-112 beds
  • Same-state prioritization (n=85)
  • Comp margins: P25=-25.1% / P50=-3.3% / P75=4.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.